Title:
CRYSTAL FORM OF UPADACITINIB, PREPARATION METHOD THEREFOR, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/007629
Kind Code:
A1
Abstract:
A new crystal form of upadacitinib and a preparation method therefor, a pharmaceutical composition containing the crystal form, and the use of the crystal form in the preparation of a JAK1 inhibitor drug and drugs for treating rheumatic arthritis, Crohn's disease, ulcerative colitis, atopic dermatitis, and psoriatic arthritis. Compared with the prior art, the crystal form of upadacitinib has one or more improved characteristics and is of great value for the optimization and development of drugs in the future.
More Like This:
Inventors:
CHEN MINHUA (CN)
ZHANG JING (CN)
ZHANG JING (CN)
Application Number:
PCT/CN2021/101784
Publication Date:
January 13, 2022
Filing Date:
June 23, 2021
Export Citation:
Assignee:
CRYSTAL PHARMACEUTICAL SUZHOU CO LTD (CN)
International Classes:
C07D487/14; A61K31/4985; A61P29/00; A61P35/00
Domestic Patent References:
| WO2020115212A1 | 2020-06-11 | |||
| WO2020115213A1 | 2020-06-11 | |||
| WO2017066775A1 | 2017-04-20 | |||
| WO2020063939A1 | 2020-04-02 | |||
| WO2020115213A1 | 2020-06-11 |
Foreign References:
| CN108368121A | 2018-08-03 |
Download PDF:
Previous Patent: ROBOTIC SYSTEM AND EXIT METHOD
Next Patent: FIXING BUCKLE FOR PLUG-IN SMALL FUSE-TYPE SWITCH DEVICE
Next Patent: FIXING BUCKLE FOR PLUG-IN SMALL FUSE-TYPE SWITCH DEVICE